These characters make EBI2 a precisely controlled GPCR at its expression and signaling levels by IFN‐related regulators (i.e., IFN‐γ, oxysterol, STAT, IFN‐I, and ISGs) during the development of SLE. Here, GPR183 is linked to systemic lupus erythematosus.